Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chemokine-like protein TAFA-3 (TAFA3, FAM19A3) is a small secreted protein, distantly related to the CC-chemokine family, and is part of the TAFA/FAM19A family. It is predominantly expressed in specific brain regions and is proposed to function as a brain-specific chemokine or neurokine, acting as a regulator of immune and nervous cells. TAFA-3 is involved in the regulation of microglia polarization and neuroblast differentiation, linking it to essential neuroimmune and developmental processes. Disruption in TAFA3 function in animal models results in altered social behavior, impaired communication, and increased repetitive behaviors, suggesting a key role in brain physiology and possibly in neuropsychiatric diseases[1][2][5][6][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chemokine-like protein TAFA-3 (TAFA3).